White paper

Generic Drugs: Market Access and Pricing in Europe

Generic Drugs: Market Access and Pricing in Europe

Author: Peter Wittner

The generics industry is an unpredictable environment that is constantly changing. It is probably quite realistic to also describe the generics business as a Darwinian world where companies need to evolve to survive. Those that do not evolve will be overtaken or eaten by more efficient competitors that do know how to evolve. The motto is 'Evolve or become extinct'! What if part of the survival strategy requires us to move from the comfort of our familiar home market into another national market as part of our expansion?

We hope you enjoy reading our white paper 'Generic Drugs: Market Access & Pricing in the EU'.






 

 

Download

White paper

Generic Drugs: Market Access and Pricing in Europe

Download

Download

Once you have completed the following fields, you can download the desired content. Alternatively, log in to your customer portal. The document will then be freely available to you.
I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
Privacy Policy 
5 + 3 =   

Events for „Market Acces“

Do filter
Sort
Tiles
Lists
Qualifikationslehrgang zum Market Access Manager

Das FORUM Institut für Management möchte Sie in Ihrer Fort- und Weiterbildung nachhaltig unterstützen. Aus diesem Grund bieten wir Ihnen neben unseren tradierten Intensivseminaren und Konferenzen einen modularen Qualifikationslehrgang im Bereich Market Access und Healthcare Management an. Er bietet Ihnen maßgeschneiderte Weiterbildung, genau auf Ihre Bedürfnisse abgestimmt.

Qualifikationslehrgang Einstieg jederzeit möglich
Pharma Pricing under Pressure: U.S. Reforms and Potential Implications for the EU Industry

Discover how recent U.S. pharmaceutical pricing reforms may affect the European pharma sector. This online seminar provides a transatlantic perspective on policy trends, trade risks, and pricing dynamics, focusing on the latest U.S. reforms such as the Most Favored Nation (MFN) mechanism, new tariffs, and direct sales models in the pharmaceutical industry.

online 08/12/2025
Strategic Market Access in Europe: From HTA to Pricing Negotiations

This online seminar provides a comprehensive introduction to drug market access and pricing strategies in five key European countries: Germany, Spain, the UK, Italy, and France. Designed for beginners and professionals seeking structured insights into HTA systems, stakeholder roles, and pricing negotiations.

online 09 - 10/12/2025
Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas covered

online 19/01/2026
All about ATMP

Das Online-Seminar zu den Themen Entwicklung, Qualität, CMC, Zulassung und Market Access für ATMPs.

online 23 - 24/03/2026